MENU
RAPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
RAPT Therapeutics (RAPT) Ownership - Who owns RAPT Therapeutics?
Profile
Industry
N/A
Address
561 Eccles Avenue
Phone
+1 650 489-9000
Employees
131
Web
https://www.rapt.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.4M
P/E Ratio
N/A
Total Cash
97.91M
Projected Growth
N/A
Total Debt
5.12M
Revenue
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
2.80
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RAPT
Capitalization
29.4M
P/E Ratio
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
97.9M
Total Cash/Share
2.80
Total Debt
5.12M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
95.5M
P/B Ratio
0.31
Cash Flow
N/A
Earnings
-2.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
9.90
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-113.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-69.76
Shares Held By Institutions
200M
Shares Outstanding - Current
35M
Total Liabilities
13M
Total Volume MTD
N/A
Value
-1
Gain YTD
-96.615
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage immunology-based biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
561 Eccles Avenue
Phone
+1 650 489-9000
Employees
131
Web
https://www.rapt.com